Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis Apre una nuova scheda del browser
(2015)
Inizio contenuto principale del sito
(2015)
(2015)
(2015)
(2015)
(2015)
(2015)
(2015)
(2015)
(2015)
(2015)